Most incretin weight-loss therapies are injected subcutaneously, but oral semaglutide is already licensed in the UK for T2DM as Rybelsus, while its manufacturer Novo Nordisk has published positive phase III results (OASIS-4, NCT05564117) for its 25mg semaglutide pill for weight loss 6
What happens if I want to stop treatment
Physiological functions [edit source] GLP-1 possesses several physiological properties making it (and its functional analogs) a subject of intensive investigation as a potential treatment of diabetes mellitus, as these actions induce long-term improvements along with the immediate effects
JAMA Netw Open 7(10):e2439887e2439887 Wang L, Wang W, Kaelber DC, Xu R, Berger NA (2024) GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity
Here are some others: Pancreatitis Pancreatitis is the inflammation or swelling of the pancreas and can, on rare occasions, potentially be triggered by GLP-1 drugs like Ozempic
Some GLP-1 users report low energy from eating less, while others find they have fewer crashes, perhaps because of better blood sugar regulation
